Australia Pneumococcal Vaccine Market Assessment, By Type of vaccine [Live attenuated vaccine, Inactivated vaccine and Subunit vaccine], By Adjuvant [Adjuvanted and Non-adjuvanted], By Route of Administration [Intramuscular, Subcutaneous, Intradermal, Others], By Age group [Infants, Children and Adult], By End-user [Hospitals, Specialty clinics, Homecare, Others], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy Government, Non-Governmental Organisations], By Region, By Opportunities and Forecast, 2016-2030F

Australia Pneumococcal Vaccine Market size was valued at USD 146.21 million in 2022 which is expected to grow to USD 189.13 billion in 2030 with a CAGR of 3.27% for the forecast period between 2023 and 2030F.

Australia Pneumococcal Vaccine Market Size, Share & Forecast 2030

Australia Pneumococcal Vaccine Market Assessment, Opportunities and Forecast, 2016-2030F

Australia Pneumococcal Vaccine Market size was valued at USD 146.21 million in 2022, expected to reach USD 189.13 million in 2030 with a CAGR of 3.27% for the forecast period between 2023 and 2030. 

FAQs

Industry Reports

Blogs

Case Studies

Industry News

Press Release

Infographics